Skip to main content
OpenTrials

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment

NCT03615066

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • University of Calgary Liver Unit - Heritage Medical Research Clinic Calgary, Alberta, Canada
  • University Health Network, Toronto General Hospital, Toronto Centre for Liver Disease Toronto, Ontario, Canada
  • Toronto Liver Centre Toronto, Ontario, Canada
  • Seoul National University Hospital Seoul, South Korea
View Trial Details
Completed

Follow-up of HBsAg Inactive Carriers Study

NCT02247752

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Ch General Du Pays D'Aix Aix-en-Provence, France
  • CH d'AVIGNON Avignon, France
  • Clinique de La Chataigneraie Beaumont, France
  • Medical Center Besancon Besançon, France
View all 32 locations
View Trial Details
Completed

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

NCT02428491

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations
  • Preventive Medicine Centre of Thai Binh Province Thái Bình, Vietnam
View Trial Details

Related conditions